Efficacy and tolerability of enteral formulations of ibuprofen in the treatment of patent ductus arteriosus in preterm infants

Clinical Therapeutics

Volumn 32, Issue 10, 2010, Pages 1740-1748

  Gouyon, Jean Bernard ^a   Kibleur, Yves ^b  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b Orphan Europe   (France)

Author keywords

Cost; Enteral; Ibuprofen; Methodology; NEC; PDA; Preterm infant

Indexed keywords

IBUPROFEN; INDOMETACIN;

ARTICLE; DRUG EFFICACY; DRUG ELIMINATION; DRUG TOLERABILITY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFANT; MAXIMUM PLASMA CONCENTRATION; NECROTIZING ENTEROCOLITIS; PATENT DUCTUS ARTERIOSUS; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CLINICAL TRIALS AS TOPIC; DUCTUS ARTERIOSUS, PATENT; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; TREATMENT OUTCOME;

EID: 78650589852     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.08.011     Document Type: Article

References (43)

1. Eichenwald EC, Stark AR Management and outcomes of very low birth weight. N Engl J Med. 2008, 358:1700-1711.
2. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med. 2000, 343:674-681.
3. Lago P, Bettiol T, Salvadori S, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: A randomised controlled trial. Eur J Pediatr. 2002, 161:202-207.
4. Clyman RI, Mauray F, Roman C, et al. Factors determining the loss of ductus arteriosus responsiveness to prostaglandin E. Circulation 1983, 68:433-436.
5. Hammerman C, Kaplan M Patent ductus arteriosus in the premature neonate: Current concepts in pharmacological management. Paediatr Drugs. 1999, 1:81-92.
6. Ryder RW, Shelton JD, Guinan ME Necrotizing enterocolitis: A prospective multicenter investigation. Am J Epidemiol. 1980, 112:113-123.
7. Cassady G, Crouse DT, Kirklin JW, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med. 1989, 320:1511-1516.
8. Fanaroff AA, Stoll BJ, Wright LL, et al. Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol. 2007, 196:147.e1-147.e8. NICHD Neonatal Research Network.
9. Nagaraj HS, Sandhu AS, Cook LN, et al. Gastrointestinal perforation following indomethacin therapy in very low birth weight infants. J Pediatr Surg. 1981, 16:1003-1007.
10. Alpan G, Eyal F, Vinograd I, et al. Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr. 1985, 106:277-281.
11. Shorter NA, Liu JY, Mooney DP, Harmon BJ Indomethacin-associated bowel perforations: A study of possible risk factors. J Pediatr Surg. 1999, 34:442-444.
12. Adams SS, McCullough KF, Nicholson JS The pharmacological properties of ibuprofen, an anti-inflammatory, analgesic and anti-pyretic agent. Arch Int Pharmacodyn Ther. 1969, 178:115-129.
13. Müller P, Simon B Effects of ibuprofen lysinate and acetylsalicylic acid on gastric and duodenal mucosa. Randomized single-blind placebo-controlled endoscopic study in healthy volunteers. Arzneimittelforschung 1994, 44:840-843.
14. Bjarnason I, Williams P, Smethurst P, et al. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut. 1986, 27:1292-1297.
15. Akisü M, Özyürek AR, Dorak C, et al. Enteral ibuprofen versus indomethacin in the treatment of PDA in preterm newborn infants [in Turkish]. Çocuk Sagligi ve Hastaliklari Dergisi 2001, 44:56-60.
16. Hariprasad P, Sundarrajan V, Srimathy G, et al. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatr. 2002, 39:99-100.
17. Supapannachart S, Limrungsikul A, Khowsathit P Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: A randomized trial at Ramathibodi Hospital. J Med Assoc Thai 2002, 85(Suppl 4):S1252-S1258.
18. Heyman E, Morag I, Batash D, et al. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: A pilot study. Pediatrics 2003, 112:e354.
19. Chotigeat U, Jirapapa K, Layangkool T A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai 2003, 86(Suppl 3):S563-S569.
20. Sangtawesin V, Sangtawesin C, Raksasinborisut C, et al. Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. J Med Assoc Thai 2006, 89:314-321.
21. Aly H, Lotfy W, Badrawi N, et al. Oral Ibuprofen and ductus arteriosus in premature infants: A randomized pilot study. Am J Perinatol. 2007, 24:267-270.
22. Fakhraee SH, Badiee Z, Mojtahedzadeh S, et al. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi 2007, 9:399-403.
23. Cherif A, Jabnoun S, Khrouf N Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am J Perinatol. 2007, 24:339-345.
24. Pourarian S, Pishva N, Madani A, Rastegari M Comparison of oral ibuprofen and indomethacin on closure of patent ductus arteriosus in preterm infants. East Mediterr Health J. 2008, 14:360-365.
25. Cherif A, Khrouf N, Jabnoun S, et al. Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus. Pediatrics. 2008, 122:e1256-e1261.
26. Manjunath S, Hariram M Study of efficacy of oral ibuprofen in preterm neonates with PDA and impact on short term clinical variables. Early Hum Dev. 2008, 84(Suppl):S154.
27. Salama H, Alsisi A, Al-Rifai H, et al. A randomized controlled trial on the use of oral ibuprofen to close patent ductus arteriosus in premature infants. J Neonatal Perinatal Med. 2008, 1:153-158.
28. Erdeve O, Sarici SU, Sari E, Gok F Oral-ibuprofen-induced acute renal failure in a preterm infant. Pediatr Nephrol. 2008, 23:1565-1567.
29. Erdeve O, Gokmen T, Altug N, Dilmen U Oral versus intravenous ibuprofen: Which is better in closure of patent ductus arteriosus?. Pediatrics 2009, 123:e763.
30. Guimarães H, Rocha G, Tomé T, et al. Non-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newborns. J Matern Fetal Neonatal Med. 2009, 22(Suppl 3):77-80.
31. Pedea 5 mg/mL solution for injection-summary of product characteristics Accessed August 10, 2010. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/000549/human_med_000973.jsp&murl=menus/medicines/medicines.jsp&mid=WC0b01ac058001d124.
32. Pezzati M, Vangi V, Biagiotti R, et al. Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr. 1999, 135:733-738.
33. Moher D, Liberati A, Tetzlaff J, Altman DG Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Ann Intern Med. 2009, 151:264-269. PRISMA Group, W64.
34. Sharma PK, Garg SK, Narang A Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol. 2003, 43:968-973.
35. Barzilay B, Batash D, Keidar R, et al. Oral ibuprofen maintains therapeutic levels for longer time compared to intravenous ibuprofen in preterm infants. Presented at: 50th Annual Meeting of the European Society for Paediatric Research October 9-12, 2009.
36. Poon G Ibuprofen lysine (Neo-Profen) for the treatment of patent ductus arteriosus. Proc (Baylor Univ Med Cent) 2007, 20:83-85.
37. Davies NM Clinical pharmacokinetics of ibuprofen. The first 30 years. Clin Pharmacokinet. 1998, 34:101-154.
38. Konstan MW, Hoppel CL, Chai BL, Davis PB Ibuprofen in children with cystic fibrosis: Pharmacokinetics and adverse effects. J Pediatr. 1991, 118:956-964.
39. Nahata MC, Durrell DE, Powell DA, Gupta N Pharmacokinetics of ibuprofen in febrile children. Eur J Clin Pharmacol. 1991, 40:427-428.
40. Van Overmeire B, Touw D, Schepens PJ, et al. Ibuprofen pharmacokinetics in preterm infants with patent ductus arteriosus. Clin Pharmacol Ther. 2001, 70:336-343.
41. Clyman RI Medical treatment of patent ductus arteriosus in premature infants. Fetal and Neonatal Cardiology 1990, 64-75. WB Saunders, Philadelphia, Pa. W.A. Long (Ed.).
42. Ohlsson A, Walia R, Shah SS Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2010, (4):CD003481.
43. Pereira-da-Silva L, Pita A, Virella D, Serelha M Oral ibuprofen for patent ductus arteriosus closure in preterm infants: Does high osmolality matter?. Am J Perinatol. 2008, 25:319-320.